{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:18:27Z","timestamp":1793197107312,"version":"4.5.0"},"reference-count":105,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"unspecified","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["ERC-2015-AdG 694679"],"award-info":[{"award-number":["ERC-2015-AdG 694679"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University Hospitals Leuven and the Research Council KU Leuven","award":["Clinical Research Fund (KOOR)"],"award-info":[{"award-number":["Clinical Research Fund (KOOR)"]}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Gastroenterol"],"accepted":{"date-parts":[[2022,10,25]]},"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To infer potential mechanisms driving disease subtypes among patients with inflammatory bowel disease (IBD), we profiled the transcriptome of purified circulating monocytes and CD4 T-cells.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>RNA extracted from purified monocytes and CD4 T-cells derived from the peripheral blood of 125 endoscopically active patients with IBD was sequenced using Illumina HiSeq 4000NGS. We used complementary supervised and unsupervised analytical methods to infer gene expression signatures associated with demographic\/clinical features. Expression differences and specificity were validated by comparison with publicly available single cell datasets, tissue-specific expression and meta-analyses. Drug target information, druggability and adverse reaction records were used to prioritise disease subtype-specific therapeutic targets.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Unsupervised\/supervised methods identified significant differences in the expression profiles of CD4 T-cells between patients with ileal Crohn\u2019s disease (CD) and ulcerative colitis (UC). Following a pathway-based classification (Area Under Receiver Operating Characteristic - AUROC=86%) between ileal-CD and UC patients, we identified MAPK and FOXO pathways to be downregulated in UC. Coexpression module\/regulatory network analysis using systems-biology approaches revealed mediatory core transcription factors. We independently confirmed that a subset of the disease location-associated signature is characterised by T-cell-specific and location-specific expression. Integration of drug-target information resulted in the discovery of several new (<jats:italic>BCL6<\/jats:italic>, <jats:italic>GPR183<\/jats:italic>, <jats:italic>TNFAIP3<\/jats:italic>) and repurposable drug targets (<jats:italic>TUBB2A<\/jats:italic>, <jats:italic>PRKCQ<\/jats:italic>) for ileal CD as well as novel targets (<jats:italic>NAPEPLD<\/jats:italic>, <jats:italic>SLC35A1<\/jats:italic>) for UC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Transcriptomic profiling of circulating CD4 T-cells in patients with IBD demonstrated marked molecular differences between the IBD-spectrum extremities (UC and predominantly ileal CD, sandwiching colonic CD), which could help in prioritising particular drug targets for IBD subtypes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjgast-2022-001003","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T11:06:39Z","timestamp":1675681599000},"page":"e001003","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Distinct transcriptional signatures in purified circulating immune cells drive heterogeneity in disease location in IBD"],"prefix":"10.1136","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct00006276","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00006276","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00572585","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00296556","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03163966","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3898-7093","authenticated-orcid":false,"given":"Bram","family":"Verstockt","sequence":"first","affiliation":[{"name":"KU Leuven Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID), IBD group, KU Leuven, Leuven, Belgium"},{"name":"Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6222-8527","authenticated-orcid":false,"given":"Sare","family":"Verstockt","sequence":"additional","affiliation":[{"name":"KU Leuven Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID), IBD group, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Cremer","sequence":"additional","affiliation":[{"name":"KU Leuven Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID), IBD group, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Sabino","sequence":"additional","affiliation":[{"name":"KU Leuven Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID), IBD group, KU Leuven, Leuven, Belgium"},{"name":"Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ferrante","sequence":"additional","affiliation":[{"name":"KU Leuven Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID), IBD group, KU Leuven, Leuven, Belgium"},{"name":"Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Vermeire","sequence":"additional","affiliation":[{"name":"KU Leuven Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID), IBD group, KU Leuven, Leuven, Belgium"},{"name":"Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1907-4491","authenticated-orcid":false,"given":"Padhmanand","family":"Sudhakar","sequence":"additional","affiliation":[{"name":"KU Leuven Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID), IBD group, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"key":"2025073012534655000_10.1.e001003.1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30333-4"},{"key":"2025073012534655000_10.1.e001003.2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.136"},{"key":"2025073012534655000_10.1.e001003.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00424-6"},{"key":"2025073012534655000_10.1.e001003.4","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1053\/j.gastro.2021.12.246","article-title":"Time to revisit disease classification in IBD: is the current classification of IBD good enough for optimal clinical management?","volume":"162","author":"Verstockt","year":"2022","journal-title":"Gastroenterology"},{"key":"2025073012534655000_10.1.e001003.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00465-1"},{"key":"2025073012534655000_10.1.e001003.6","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjy146"},{"key":"2025073012534655000_10.1.e001003.7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318343"},{"key":"2025073012534655000_10.1.e001003.8","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2019.1677608"},{"key":"2025073012534655000_10.1.e001003.9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222952","article-title":"Concordance between gene expression in peripheral whole blood and colonic tissue in children with inflammatory bowel disease","volume":"14","author":"Palmer","year":"2019","journal-title":"PLoS One"},{"key":"2025073012534655000_10.1.e001003.10","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10040872","article-title":"Gelsolin as a potential biomarker for endoscopic activity and mucosal healing in ulcerative colitis","volume":"10","author":"Maeda","year":"2022","journal-title":"Biomedicines"},{"key":"2025073012534655000_10.1.e001003.11","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/ecco-jcc\/jjx091","article-title":"Usefulness of transcriptional blood biomarkers as a non-invasive surrogate marker of mucosal healing and endoscopic response in ulcerative colitis","volume":"11","author":"Planell","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2025073012534655000_10.1.e001003.12","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315494"},{"key":"2025073012534655000_10.1.e001003.13","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1053\/j.gastro.2017.07.047","article-title":"Circulating and tissue-resident CD4+ T Cells with reactivity to intestinal microbiota are abundant in healthy individuals and function Is Altered during Inflammation","volume":"153","author":"Hegazy","year":"2017","journal-title":"Gastroenterology"},{"key":"2025073012534655000_10.1.e001003.14","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/ibd\/izx106","article-title":"Inverse association between circulating monocyte-platelet complexes and inflammation in ulcerative colitis patients","volume":"24","author":"Zamora","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2025073012534655000_10.1.e001003.15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/ibd\/izaa151","article-title":"Profiling of human circulating dendritic cells and monocyte subsets discriminates between type and mucosal status in patients with inflammatory bowel disease","volume":"27","author":"Ortega Moreno","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"2025073012534655000_10.1.e001003.16","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/ibd\/izaa281","article-title":"Understanding the molecular drivers of disease heterogeneity in Crohn\u2019s disease using multi-omic data integration and network analysis","volume":"27","author":"Sudhakar","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"2025073012534655000_10.1.e001003.17","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3317"},{"key":"2025073012534655000_10.1.e001003.18","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu638"},{"key":"2025073012534655000_10.1.e001003.19","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20178124"},{"key":"2025073012534655000_10.1.e001003.20","doi-asserted-by":"crossref","unstructured":"Almeida-Silva F , Venancio TM . BioNERO: an all-in-one R\/Bioconductor package for comprehensive and easy biological network reconstruction. BioRxiv.doi:10.1101\/2021.04.10.439287","DOI":"10.1101\/2021.04.10.439287"},{"key":"2025073012534655000_10.1.e001003.21","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8"},{"key":"2025073012534655000_10.1.e001003.22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005752"},{"key":"2025073012534655000_10.1.e001003.23","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20188497"},{"key":"2025073012534655000_10.1.e001003.24","doi-asserted-by":"publisher","DOI":"10.1039\/C5MB00663E"},{"key":"2025073012534655000_10.1.e001003.25","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118"},{"key":"2025073012534655000_10.1.e001003.26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559"},{"key":"2025073012534655000_10.1.e001003.27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz446"},{"key":"2025073012534655000_10.1.e001003.28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.tig.2016.02.002","article-title":"Deciphering encode","volume":"32","author":"Diehl","year":"2016","journal-title":"Trends Genet"},{"key":"2025073012534655000_10.1.e001003.29","first-page":"D180","article-title":"ReMap 2020: a database of regulatory regions from an integrative analysis of human and Arabidopsis DNA-binding sequencing experiments","volume":"48","author":"Ch\u00e8neby","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2025073012534655000_10.1.e001003.30","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2653"},{"key":"2025073012534655000_10.1.e001003.31","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3838"},{"key":"2025073012534655000_10.1.e001003.32","doi-asserted-by":"publisher","DOI":"10.1002\/pro.3307"},{"key":"2025073012534655000_10.1.e001003.33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97366-5","article-title":"Meta-analysis of gene expression disease signatures in colonic biopsy tissue from patients with ulcerative colitis","volume":"11","author":"Linggi","year":"2021","journal-title":"Sci Rep"},{"key":"2025073012534655000_10.1.e001003.34","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1133"},{"key":"2025073012534655000_10.1.e001003.35","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000001246"},{"key":"2025073012534655000_10.1.e001003.36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007984"},{"key":"2025073012534655000_10.1.e001003.37","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.27"},{"key":"2025073012534655000_10.1.e001003.38","doi-asserted-by":"publisher","DOI":"10.1038\/nature11582"},{"key":"2025073012534655000_10.1.e001003.39","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2016.34"},{"key":"2025073012534655000_10.1.e001003.40","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa1084"},{"key":"2025073012534655000_10.1.e001003.41","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.chembiol.2017.11.009","article-title":"Drug target commons: a community effort to build a consensus knowledge base for drug-target interactions","volume":"25","author":"Tang","year":"2018","journal-title":"Cell Chem Biol"},{"key":"2025073012534655000_10.1.e001003.42","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1277"},{"key":"2025073012534655000_10.1.e001003.43","unstructured":"FDA Adverse Event Reporting System . FDA adverse event reporting system. Available: https:\/\/open.fda.gov\/data\/faers\/ [Accessed 31 Mar 2022]."},{"key":"2025073012534655000_10.1.e001003.44","unstructured":"MedEffect . Available: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medeffect-canada\/medeffect-canada.html#a1 [Accessed 31 Mar 2022]."},{"key":"2025073012534655000_10.1.e001003.45","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1075"},{"key":"2025073012534655000_10.1.e001003.46","unstructured":"Offsides . Available: http:\/\/tatonettilab.org\/offsides\/ [Accessed 31 Mar 2022]."},{"key":"2025073012534655000_10.1.e001003.47","doi-asserted-by":"crossref","DOI":"10.1038\/npjsba.2016.15","article-title":"L1000CDS2: LINCS L1000 characteristic direction signatures search engine","volume":"2","author":"Duan","year":"2016","journal-title":"NPJ Syst Biol Appl"},{"key":"2025073012534655000_10.1.e001003.48","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ebiom.2019.01.027","article-title":"Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease","volume":"40","author":"Verstockt","year":"2019","journal-title":"EBioMedicine"},{"key":"2025073012534655000_10.1.e001003.49","first-page":"2640","article-title":"MiR-195 alleviates ulcerative colitis in rats via MAPK signaling pathway","volume":"24","author":"Bai","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2025073012534655000_10.1.e001003.50","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2012.177"},{"key":"2025073012534655000_10.1.e001003.51","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.biopha.2014.09.006","article-title":"Upregulation of MAPK\/Erk and PI3K\/Akt pathways in ulcerative colitis-associated colon cancer","volume":"68","author":"Setia","year":"2014","journal-title":"Biomed Pharmacother"},{"key":"2025073012534655000_10.1.e001003.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.08.034"},{"key":"2025073012534655000_10.1.e001003.53","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109867","article-title":"Overexpressed FOXO3 improves inflammatory status in mice by affecting NLRP3-mediated cell coronation in necrotizing colitis mice","volume":"125","author":"Yin","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"2025073012534655000_10.1.e001003.54","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2009.66"},{"key":"2025073012534655000_10.1.e001003.55","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1111\/jcmm.15075","article-title":"FoxO1 regulates TLR4\/MyD88\/MD2-NF-\u03baB inflammatory signalling in mucosal barrier injury of inflammatory bowel disease","volume":"24","author":"Han","year":"2020","journal-title":"J Cell Mol Med"},{"key":"2025073012534655000_10.1.e001003.56","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00227-08"},{"key":"2025073012534655000_10.1.e001003.57","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.4103\/0366-6999.167314","article-title":"Expression of transcription factor FOXO3a is decreased in patients with ulcerative colitis","volume":"128","author":"Min","year":"2015","journal-title":"Chin Med J"},{"key":"2025073012534655000_10.1.e001003.58","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/CEG.S61868","article-title":"Managing refractory Crohn's disease: challenges and solutions","volume":"8","author":"Tanida","year":"2015","journal-title":"Clin Exp Gastroenterol"},{"key":"2025073012534655000_10.1.e001003.59","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.cgh.2019.04.040","article-title":"Should we divide Crohn's disease into Ileum-dominant and isolated colonic diseases?","volume":"17","author":"Dulai","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025073012534655000_10.1.e001003.60","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/apt.15862","article-title":"Letter: choosing between ustekinumab and vedolizumab in anti-TNF refractory Crohn's disease-the devil is in the detail","volume":"52","author":"Srinivasan","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2025073012534655000_10.1.e001003.61","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.587445","article-title":"Case report: IL-21 and BCL-6 regulate the proliferation and secretion of Tfh and TFR cells in the intestinal germinal center of patients with inflammatory bowel disease","volume":"11","author":"Yang","year":"2020","journal-title":"Front Pharmacol"},{"key":"2025073012534655000_10.1.e001003.62","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201794"},{"key":"2025073012534655000_10.1.e001003.63","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20182376"},{"key":"2025073012534655000_10.1.e001003.64","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1172\/JCI98929","article-title":"Intestinal development and homeostasis require activation and apoptosis of diet-reactive T cells","volume":"129","author":"Visekruna","year":"2019","journal-title":"J Clin Invest"},{"key":"2025073012534655000_10.1.e001003.65","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/ecco-jcc\/jjaa021","article-title":"A pilot integrative analysis of colonic gene expression, gut microbiota, and immune infiltration in primary sclerosing Cholangitis-inflammatory bowel disease: association of disease with bile acid pathways","volume":"14","author":"Quraishi","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2025073012534655000_10.1.e001003.66","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07735-4","article-title":"JunB regulates homeostasis and suppressive functions of effector regulatory T cells","volume":"9","author":"Koizumi","year":"2018","journal-title":"Nat Commun"},{"key":"2025073012534655000_10.1.e001003.67","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41586-019-0979-8","article-title":"Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction","volume":"567","author":"Liu","year":"2019","journal-title":"Nature"},{"key":"2025073012534655000_10.1.e001003.68","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2019.00349","article-title":"Sustained Egr-1 response via p38 MAP kinase signaling modulates early immune responses of dendritic cells parasitized by Toxoplasma gondii","volume":"9","author":"Ten Hoeve","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"2025073012534655000_10.1.e001003.69","first-page":"7537","article-title":"MAPK\/c-Jun signaling pathway contributes to the upregulation of the anti-apoptotic proteins Bcl-2 and Bcl-xL induced by Epstein-Barr virus-encoded BARF1 in gastric carcinoma cells","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol Lett"},{"key":"2025073012534655000_10.1.e001003.70","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27020536","article-title":"Small drugs, huge impact: the extraordinary impact of antisense oligonucleotides in research and drug development","volume":"27","author":"Quemener","year":"2022","journal-title":"Molecules"},{"key":"2025073012534655000_10.1.e001003.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2010.03.006"},{"key":"2025073012534655000_10.1.e001003.72","doi-asserted-by":"publisher","DOI":"10.1002\/path.4670"},{"key":"2025073012534655000_10.1.e001003.73","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1412308111"},{"key":"2025073012534655000_10.1.e001003.74","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.12483"},{"key":"2025073012534655000_10.1.e001003.75","doi-asserted-by":"crossref","first-page":"G280","DOI":"10.1152\/ajpgi.00338.2019","article-title":"Nr4A1 modulates inflammation-associated intestinal fibrosis and dampens fibrogenic signaling in myofibroblasts","volume":"321","author":"Pulakazhi Venu","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2025073012534655000_10.1.e001003.76","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.06.038"},{"key":"2025073012534655000_10.1.e001003.77","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601416"},{"key":"2025073012534655000_10.1.e001003.78","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/ecco-jcc\/jjy179","article-title":"Critical role of cd6highcd4+ T cells in driving Th1\/Th17 cell immune responses and mucosal inflammation in IBD","volume":"13","author":"Ma","year":"2019","journal-title":"J Crohns Colitis"},{"key":"2025073012534655000_10.1.e001003.79","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/bph.14667","article-title":"Inhibition of phosphodiesterase-4 attenuates murine ulcerative colitis through interference with mucosal immunity","volume":"176","author":"Li","year":"2019","journal-title":"Br J Pharmacol"},{"key":"2025073012534655000_10.1.e001003.80","doi-asserted-by":"crossref","DOI":"10.1093\/crocol\/otz026","article-title":"Elevated pretreatment plasma oncostatin M is associated with poor biochemical response to infliximab","volume":"1","author":"Minar","year":"2019","journal-title":"Crohns Colitis 360"},{"key":"2025073012534655000_10.1.e001003.81","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izab032"},{"key":"2025073012534655000_10.1.e001003.82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000508069","article-title":"Plasma oncostatin M, TNF-\u03b1, IL-7, and IL-13 network predicts Crohn's disease response to infliximab, as assessed by calprotectin log drop","volume":"39","author":"Mateos","year":"2021","journal-title":"Dig Dis"},{"key":"2025073012534655000_10.1.e001003.83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093498"},{"key":"2025073012534655000_10.1.e001003.84","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4307"},{"key":"2025073012534655000_10.1.e001003.85","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201406055"},{"key":"2025073012534655000_10.1.e001003.86","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaci.2017.11.024","article-title":"TNF-\u03b1-induced protein 3 (TNFAIP3)\/A20 acts as a master switch in TNF-\u03b1 blockade-driven IL-17A expression","volume":"142","author":"Urbano","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2025073012534655000_10.1.e001003.87","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1080\/15548627.2019.1628549","article-title":"The anti-inflammatory protein TNFAIP3\/A20 binds the WD40 domain of ATG16L1 to control the autophagic response, NFKB\/NF-\u03baB activation and intestinal homeostasis","volume":"15","author":"Serramito-G\u00f3mez","year":"2019","journal-title":"Autophagy"},{"key":"2025073012534655000_10.1.e001003.88","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95063","article-title":"Single-cell profiling reveals GPCR heterogeneity and functional patterning during neuroinflammation","volume":"2","author":"Tischner","year":"2017","journal-title":"JCI Insight"},{"key":"2025073012534655000_10.1.e001003.89","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.601534","article-title":"GPR183 regulates interferons, autophagy, and bacterial growth during Mycobacterium tuberculosis infection and Is associated with TB disease severity","volume":"11","author":"Bartlett","year":"2020","journal-title":"Front Immunol"},{"key":"2025073012534655000_10.1.e001003.90","doi-asserted-by":"publisher","DOI":"10.1038\/nature17947"},{"key":"2025073012534655000_10.1.e001003.91","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2120"},{"key":"2025073012534655000_10.1.e001003.92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00197"},{"key":"2025073012534655000_10.1.e001003.93","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.10.051"},{"key":"2025073012534655000_10.1.e001003.94","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2016.44"},{"key":"2025073012534655000_10.1.e001003.95","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1181"},{"key":"2025073012534655000_10.1.e001003.96","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jaci.2018.05.036","article-title":"T cell-intrinsic prostaglandin E2-EP2\/EP4 signaling is critical in pathogenic TH17 cell-driven inflammation","volume":"143","author":"Lee","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2025073012534655000_10.1.e001003.97","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.05.004"},{"key":"2025073012534655000_10.1.e001003.98","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2007.01786.x"},{"key":"2025073012534655000_10.1.e001003.99","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1272"},{"key":"2025073012534655000_10.1.e001003.100","doi-asserted-by":"publisher","DOI":"10.1210\/me.2004-0529"},{"key":"2025073012534655000_10.1.e001003.101","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.091204"},{"key":"2025073012534655000_10.1.e001003.102","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2011.77"},{"key":"2025073012534655000_10.1.e001003.103","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/jlb.65.5.691","article-title":"Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo","volume":"65","author":"Annunziato","year":"1999","journal-title":"J Leukoc Biol"},{"key":"2025073012534655000_10.1.e001003.104","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ibd.20755","article-title":"Alteration of CXCR4 expression and Th1\/Th2 balance of peripheral CD4-positive T cells can be a biomarker for leukocytapheresis therapy for patients with refractory ulcerative colitis","volume":"15","author":"Nakase","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"2025073012534655000_10.1.e001003.105","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1818164116"}],"container-title":["BMJ Open Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgast-2022-001003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T19:53:56Z","timestamp":1753905236000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopengastro.bmj.com\/lookup\/doi\/10.1136\/bmjgast-2022-001003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,2,6]]},"published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1136\/bmjgast-2022-001003"],"URL":"https:\/\/doi.org\/10.1136\/bmjgast-2022-001003","relation":{},"ISSN":["2054-4774"],"issn-type":[{"value":"2054-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]}}}